{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T10:23:27Z","timestamp":1783592607837,"version":"3.55.0"},"reference-count":84,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T00:00:00Z","timestamp":1670457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Cardiovascular diseases (CVD) remain a substantial global health problem and the leading cause of death worldwide. Although many conventional small-molecule treatments are available to support the cardiac function of the patient with CVD, they are not effective as a cure. Among potential targets for gene therapy are severe cardiac and peripheral ischemia, heart failure, vein graft failure, and some forms of dyslipidemias. In the last three decades, multiple gene therapy tools have been used for heart diseases caused by proteins, plasmids, adenovirus, and adeno-associated viruses (AAV), but these remain as unmet clinical needs. These gene therapy methods are ineffective due to poor and uncontrolled gene expression, low stability, immunogenicity, and transfection efficiency. The synthetic modified mRNA (modRNA) presents a novel gene therapy approach which provides a transient, stable, safe, non-immunogenic, controlled mRNA delivery to the heart tissue without any risk of genomic integration, and achieves a therapeutic effect in different organs, including the heart. The mRNA translation starts in minutes, and remains stable for 8\u201310 days (pulse-like kinetics). The pulse-like expression of modRNA in the heart induces cardiac repair, cardiomyocyte proliferation and survival, and inhibits cardiomyocyte apoptosis post-myocardial infarction (MI). Cell-specific (cardiomyocyte) modRNA translation developments established cell-specific modRNA therapeutics for heart diseases. With these laudable characteristics, combined with its expression kinetics in the heart, modRNA has become an attractive therapeutic for the treatment of CVD. This review discusses new developments in modRNA therapy for heart diseases.<\/jats:p>","DOI":"10.3390\/ijms232415514","type":"journal-article","created":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T01:44:31Z","timestamp":1670463871000},"page":"15514","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Modified mRNA Therapeutics for Heart Diseases"],"prefix":"10.3390","volume":"23","author":[{"given":"Ajit","family":"Magadum","sequence":"first","affiliation":[{"name":"Center for Translational Medicine, Temple University, Philadelphia, PA 19140, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,8]]},"reference":[{"key":"ref_1","first-page":"e6","article-title":"American Heart Association Statistics, S. Stroke Statistics, Heart disease and stroke statistics\u20142013 update: A report from the American Heart Association","volume":"127","author":"Go","year":"2013","journal-title":"Circulation"},{"key":"ref_2","unstructured":"Reddy, S., Riahi, F., Dorling, G., Callahan, R., and Patel, H. (2016). Innovative Approaches to Prevention Tackling the Global Burden of Cardiovascular Disease, World Innovation Summit for Health."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2165\/00129784-200505060-00002","article-title":"ACE inhibitors in heart failure: What more do we need to know?","volume":"5","author":"Demers","year":"2005","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"ii3-6","DOI":"10.1136\/hrt.2005.062018","article-title":"Heart failure post-myocardial infarction: A review of the issues","volume":"91","author":"Dargie","year":"2005","journal-title":"Heart"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1126\/science.1200708","article-title":"Transient Regenerative Potential of the Neonatal Mouse Heart","volume":"331","author":"Porrello","year":"2011","journal-title":"Science"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"966","DOI":"10.18632\/aging.100526","article-title":"Complete cardiac regeneration in a mouse model of myocardial infarction","volume":"4","author":"Haubner","year":"2012","journal-title":"Aging"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1101\/gad.1306705","article-title":"p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes","volume":"19","author":"Engel","year":"2005","journal-title":"Genes Dev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature22978","article-title":"The extracellular matrix protein agrin promotes heart regeneration in mice","volume":"547","author":"Bassat","year":"2017","journal-title":"Nature"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nature15372","article-title":"Epicardial FSTL1 reconstitution regenerates the adult mammalian heart","volume":"525","author":"Wei","year":"2015","journal-title":"Nature"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/nm1619","article-title":"Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair","volume":"13","author":"Hajjar","year":"2007","journal-title":"Nat. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature11739","article-title":"Functional screening identifies miRNAs inducing cardiac regeneration","volume":"492","author":"Eulalio","year":"2012","journal-title":"Nature"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.omtn.2018.08.021","article-title":"Ablation of a Single N-Glycosylation Site in Human FSTL 1 Induces Cardiomyocyte Proliferation and Cardiac Regeneration","volume":"13","author":"Magadum","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1161\/CIRCULATIONAHA.119.043067","article-title":"Pkm2 Regulates Cardiomyocyte Cell Cycle and Promotes Cardiac Regeneration","volume":"141","author":"Magadum","year":"2020","journal-title":"Circulation"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1126\/science.1199010","article-title":"Hippo Pathway Inhibits Wnt Signaling to Restrain Cardiomyocyte Proliferation and Heart Size","volume":"332","author":"Heallen","year":"2011","journal-title":"Science"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/mt.2015.193","article-title":"Myocardial Delivery of Lipidoid Nanoparticle Carrying modRNA Induces Rapid and Transient Expression","volume":"24","author":"Turnbull","year":"2016","journal-title":"Mol. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"239rv1","DOI":"10.1126\/scitranslmed.3006681","article-title":"Strategies for Cardiac Regeneration and Repair","volume":"6","author":"Lin","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"a014035","DOI":"10.1101\/cshperspect.a014035","article-title":"Synthetic Chemically Modified mRNA (modRNA): Toward a New Technology Platform for Cardiovascular Biology and Medicine","volume":"5","author":"Chien","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1161\/CIRCRESAHA.117.311311","article-title":"RNA Therapeutics in Cardiovascular Disease","volume":"123","author":"Lucas","year":"2018","journal-title":"Circ. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1161\/CIRCRESAHA.119.315856","article-title":"Preclinical and Clinical Development of Noncoding RNA Therapeutics for Cardiovascular Disease","volume":"126","author":"Huang","year":"2020","journal-title":"Circ. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/HCO.0000000000000724","article-title":"RNA-based therapeutics in cardiovascular disease","volume":"35","author":"Pham","year":"2020","journal-title":"Curr. Opin. Cardiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"114432","DOI":"10.1016\/j.bcp.2021.114432","article-title":"The growth of siRNA-based therapeutics: Updated clinical studies","volume":"189","author":"Zhang","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/d41573-020-00078-0","article-title":"RNA therapeutics on the rise","volume":"19","author":"Wang","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1146\/annurev-biochem-060614-034316","article-title":"Mechanisms and Regulation of Alternative Pre-mRNA Splicing","volume":"84","author":"Lee","year":"2015","journal-title":"Annu. Rev. Biochem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/190576a0","article-title":"An Unstable Intermediate Carrying Information from Genes to Ribosomes for Protein Synthesis","volume":"190","author":"Brenner","year":"1961","journal-title":"Nature"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1073\/pnas.86.16.6077","article-title":"Cationic liposome-mediated RNA transfection","volume":"86","author":"Malone","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1126\/science.1690918","article-title":"Direct gene transfer into mouse muscle in vivo","volume":"247","author":"Wolff","year":"1990","journal-title":"Science"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/mt.2008.200","article-title":"Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability","volume":"16","author":"Muramatsu","year":"2008","journal-title":"Mol. Ther."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","article-title":"Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNA","volume":"23","author":"Buckstein","year":"2005","journal-title":"Immunity"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nbt.1733","article-title":"Expression of therapeutic proteins after delivery of chemically modified mRNA in mice","volume":"29","author":"Kormann","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/mt.2011.67","article-title":"Therapeutic Delivery of mRNA: The Medium Is the Message","volume":"19","author":"McIvor","year":"2011","journal-title":"Mol. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1161\/CIRCULATIONAHA.116.022064","article-title":"Insulin-Like Growth Factor 1 Receptor-Dependent Pathway Drives Epicardial Adipose Tissue Formation After Myocardial Injury","volume":"135","author":"Zangi","year":"2017","journal-title":"Circulation"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.ymthe.2017.03.016","article-title":"Optimizing Cardiac Delivery of Modified mRNA","volume":"25","author":"Sultana","year":"2017","journal-title":"Mol. Ther."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1021\/mp5006239","article-title":"Synthetic chemically modified mrna-based delivery of cytoprotective factor promotes early cardiomyocyte survival post-acute myocardial infarction","volume":"12","author":"Huang","year":"2015","journal-title":"Mol. Pharm."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/nbt.2682","article-title":"Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction","volume":"31","author":"Zangi","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1161\/CIRCULATIONAHA.119.041882","article-title":"Altering Sphingolipid Metabolism Attenuates Cell Death and Inflammatory Response After Myocardial Infarction","volume":"141","author":"Hadas","year":"2020","journal-title":"Circulation"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.omtm.2020.03.019","article-title":"Optimization of 5\u2032 Untranslated Region of Modified mRNA for Use in Cardiac or Hepatic Ischemic Injury","volume":"17","author":"Sultana","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1002\/cpz1.39","article-title":"Cap 1 Messenger RNA Synthesis with Co-transcriptional CleanCap((R)) Analog by In Vitro Transcription","volume":"1","author":"Henderson","year":"2021","journal-title":"Curr. Protoc."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e201900424","DOI":"10.26508\/lsa.201900424","article-title":"aYAP modRNA reduces cardiac inflammation and hypertrophy in a murine ischemia-reperfusion model","volume":"3","author":"Chen","year":"2019","journal-title":"Life Sci. Alliance"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.omtm.2018.04.003","article-title":"Biocompatible, Purified VEGF-A mRNA Improves Cardiac Function after Intracardiac Injection 1 Week Post-myocardial Infarction in Swine","volume":"9","author":"Carlsson","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.omtm.2019.07.006","article-title":"Optimizing Modified mRNA In Vitro Synthesis Protocol for Heart Gene Therapy","volume":"14","author":"Hadas","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1089\/ten.tea.2017.0445","article-title":"M3RNA Drives Targeted Gene Delivery in Acute Myocardial Infarction","volume":"25","author":"Singh","year":"2019","journal-title":"Tissue Eng. Part A"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/978-1-4939-6588-5_8","article-title":"Synthesis of Modified mRNA for Myocardial Delivery","volume":"1521","author":"Kondrat","year":"2010","journal-title":"Methods Mol. Bio."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/978-1-4939-6588-5_10","article-title":"Lipidoid mRNA Nanoparticles for Myocardial Delivery in Rodents","volume":"1521","author":"Turnbull","year":"2016","journal-title":"Cardiac Gene Therapy"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/cr.2013.112","article-title":"Driving Vascular endothelial cell fate of human multipotent Isl1+ heart progenitors with VEGF modified mRNA","volume":"23","author":"Lui","year":"2013","journal-title":"Cell Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.str.2004.03.015","article-title":"Structure of Protein L7Ae Bound to a K-Turn Derived from an Archaeal Box H\/ACA sRNA at 1.8 \u00c5 Resolution","volume":"12","author":"Hamma","year":"2004","journal-title":"Structure"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nbt.3301","article-title":"Mammalian synthetic circuits with RNA binding proteins for RNA-only delivery","volume":"33","author":"Wroblewska","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nrd3864","article-title":"MicroRNA therapeutics for cardiovascular disease: Opportunities and obstacles","volume":"11","author":"Olson","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ceb.2009.01.029","article-title":"MicroRNA control of muscle development and disease","volume":"21","author":"Williams","year":"2009","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1152\/physiolgenomics.00130.2010","article-title":"The role of microRNA in modulating myocardial ischemia-reperfusion injury","volume":"43","author":"Ye","year":"2011","journal-title":"Physiol. Genom."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/nature08804","article-title":"Primary contribution to zebrafish heart regeneration by gata4+ cardiomyocytes","volume":"464","author":"Kikuchi","year":"2010","journal-title":"Nature"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/jez.1401870208","article-title":"Response of the adult newt ventricle to injury","volume":"187","author":"Oberpriller","year":"1974","journal-title":"J. Exp. Zool."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nature12054","article-title":"Meis1 regulates postnatal cardiomyocyte cell cycle arrest","volume":"497","author":"Mahmoud","year":"2013","journal-title":"Nature"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/cr.2017.84","article-title":"Live cell screening platform identifies PPARdelta as a regulator of cardiomyocyte proliferation and cardiac repair","volume":"27","author":"Magadum","year":"2017","journal-title":"Cell Res."},{"key":"ref_55","first-page":"627","article-title":"ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation","volume":"17","author":"Aharonov","year":"2015","journal-title":"Nature"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.cell.2009.04.060","article-title":"Neuregulin1\/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury","volume":"138","author":"Bersell","year":"2009","journal-title":"Cell"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.canlet.2013.06.008","article-title":"Regulation and function of pyruvate kinase M2 in cancer","volume":"339","author":"Yang","year":"2013","journal-title":"Cancer Lett."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13578-019-0317-8","article-title":"PKM2, function and expression and regulation","volume":"9","author":"Zhang","year":"2019","journal-title":"Cell Biosci."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"E899","DOI":"10.1073\/pnas.1108559108","article-title":"Cardiac myocyte follistatin-like 1 functions to attenuate hypertrophy following pressure overload","volume":"108","author":"Shimano","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"9583268","DOI":"10.1155\/2016\/9583268","article-title":"Signaling Pathways in Cardiac Myocyte Apoptosis","volume":"2016","author":"Xia","year":"2016","journal-title":"BioMed Res. Int."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1476-511X-9-15","article-title":"Ceramide and ceramide 1-phosphate in health and disease","volume":"9","author":"Arana","year":"2010","journal-title":"Lipids Heal. Dis."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.cjca.2014.12.007","article-title":"Ceramide Is Upregulated and Associated With Mortality in Patients With Chronic Heart Failure","volume":"31","author":"Yu","year":"2015","journal-title":"Can. J. Cardiol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00395-016-0533-x","article-title":"Inhibition of ceramide de novo synthesis as a postischemic strategy to reduce myocardial reperfusion injury","volume":"111","author":"Reforgiato","year":"2016","journal-title":"Basic Res. Cardiol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.yjmcc.2016.02.019","article-title":"Targeting acid sphingomyelinase reduces cardiac ceramide accumulation in the post-ischemic heart","volume":"93","author":"Klevstig","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"33110","DOI":"10.1074\/jbc.271.51.33110","article-title":"Molecular Cloning and Characterization of a Full-length Complementary DNA Encoding Human Acid Ceramidase","volume":"271","author":"Koch","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref_66","first-page":"1535","article-title":"PKM2 Knockdown Induces Autophagic Cell Death via AKT\/mTOR Pathway in Human Prostate Cancer Cells","volume":"52","author":"Dey","year":"2019","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/FJC.0000000000000003","article-title":"The immune system and the remodeling infarcted heart: Cell biological insights and therapeutic opportunities","volume":"63","author":"Frangogiannis","year":"2014","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1016\/j.jacc.2011.08.033","article-title":"Double-edged role of the CXCL12\/CXCR4 axis in experimental myocardial infarction","volume":"58","author":"Liehn","year":"2011","journal-title":"J. Am. Coll Cardiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/nature24045","article-title":"Hippo pathway deficiency reverses systolic heart failure after infarction","volume":"550","author":"Leach","year":"2017","journal-title":"Nature"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1089\/ars.2012.5149","article-title":"Reactive Oxygen Species in Inflammation and Tissue Injury","volume":"20","author":"Mittal","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/cvr\/cvn335","article-title":"Oxidative stress and left ventricular remodelling after myocardial infarction","volume":"81","author":"Hori","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1096\/fj.09-145508","article-title":"Acid ceramidase improves the quality of oocytes and embryos and the outcome of in vitro fertilization","volume":"24","author":"Eliyahu","year":"2010","journal-title":"FASEB J."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"864","DOI":"10.5114\/aoms.2016.63259","article-title":"Clinical importance of epicardial adipose tissue","volume":"4","author":"Nagy","year":"2017","journal-title":"Arch. Med. Sci."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1161\/01.CIR.0000061911.47710.8A","article-title":"The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis","volume":"107","author":"Henry","year":"2003","journal-title":"Circulation"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1161\/01.CIR.101.2.118","article-title":"Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion: Evidence for a dose-dependent effect","volume":"101","author":"Hendel","year":"2000","journal-title":"Circulation"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0735-1097(00)01144-X","article-title":"Efficacy of intracoronary or intravenous VEGF165in a pig model of chronic myocardial ischemia","volume":"37","author":"Sato","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1161\/01.CIR.0000070540.80780.92","article-title":"Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: Phase II results of the Kuopio Angiogenesis Trial (KAT)","volume":"107","author":"Hedman","year":"2003","journal-title":"Circulation"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1038\/sj.gt.3302802","article-title":"Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: A phase 2 randomized, controlled trial of AdVEGF121 (AdVEGF121) versus maximum medical treatment","volume":"13","author":"Stewart","year":"2006","journal-title":"Gene Ther."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1161\/01.CIR.98.25.2800","article-title":"Gene therapy for myocardial angiogenesis: Initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia","volume":"98","author":"Losordo","year":"1998","journal-title":"Circulation"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/mt.2009.70","article-title":"VEGF Gene Therapy Fails to Improve Perfusion of Ischemic Myocardium in Patients With Advanced Coronary Disease: Results of the NORTHERN Trial","volume":"17","author":"Stewart","year":"2009","journal-title":"Mol. Ther."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/s41467-019-08852-4","article-title":"Intradermal delivery of modified mRNA encoding VEGF-A in patients with type 2 diabetes","volume":"10","author":"Gan","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-35570-6","article-title":"Modified VEGF-A mRNA induces sustained multifaceted microvascular response and accelerates diabetic wound healing","volume":"8","author":"Sun","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/psp4.12516","article-title":"Model-Based Analysis Reveals a Sustained and Dose-Dependent Acceleration of Wound Healing by VEGF-A mRNA (AZD8601)","volume":"9","author":"Almquist","year":"2020","journal-title":"CPT Pharmacomet. Syst. Pharmacol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"5884","DOI":"10.1093\/nar\/gkq347","article-title":"Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation","volume":"38","author":"Anderson","year":"2010","journal-title":"Nucleic Acids Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/24\/15514\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:36:09Z","timestamp":1760146569000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/24\/15514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,8]]},"references-count":84,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["ijms232415514"],"URL":"https:\/\/doi.org\/10.3390\/ijms232415514","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,8]]}}}